Literature DB >> 7690980

Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells.

P Sarobe1, J J Lasarte, E Larrea, J J Golvano, I Prieto, A Gullón, J Prieto, F Borrás-Cuesta.   

Abstract

The insertion of two lysine residues (cleavage sites of cathepsin B) at the boundary of a peptide recognized by B cells (BD) and a class-II- presentable sequence (TDh) enhanced the anti-BD antibody induction capacity of this type of peptide construct, as well as production of IL2. It is postulated that these lysines generate a neoprocessable site which helps in release of the TDh moiety from the construct, enabling its presentation to class II molecules, an essential step in clonal expansion of the antibody-producing B cell after internalization of the construct via the BD moiety.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690980     DOI: 10.1016/0923-2494(93)80102-5

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


  8 in total

1.  Immunogenicity of peptides coupled with multiple T-cell epitopes of a surface protein antigen of Streptococcus mutans.

Authors:  H Senpuku; T Iizima; Y Yamaguchi; S Nagata; Y Ueno; M Saito; N Hanada; T Nisizawa
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  An antigenic peptide inducing cross-reacting antibodies inhibiting the interaction of Streptococcus mutans PAc with human salivary components.

Authors:  H Senpuku; T Miyauchi; N Hanada; T Nisizawa
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

3.  A mimotope attached to an ITIM-SHP-1 interaction inhibitory peptide boosts immune response and efficacy.

Authors:  Koushik Roy; Syamal Roy; Siddhartha Roy
Journal:  RSC Med Chem       Date:  2021-05-19

4.  Vaccination with a Paramyosin-Based Multi-Epitope Vaccine Elicits Significant Protective Immunity against Trichinella spiralis Infection in Mice.

Authors:  Yuan Gu; Ximeng Sun; Bo Li; Jingjing Huang; Bin Zhan; Xinping Zhu
Journal:  Front Microbiol       Date:  2017-08-03       Impact factor: 5.640

5.  Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.

Authors:  Theresa B Gallagher; Gabriela Mellado-Sanchez; Ana L Jorgensen; Stephen Moore; James P Nataro; Marcela F Pasetti; Les W Baillie
Journal:  PLoS Negl Trop Dis       Date:  2019-08-20

6.  An in-silico approach to develop of a multi-epitope vaccine candidate against SARS-CoV-2 envelope (E) protein.

Authors:  Fatemeh Ghafouri; Reza Ahangari Cohan; Farshid Noorbakhsh; Hilda Samimi; Vahid Haghpanah
Journal:  Res Sq       Date:  2020-05-20

7.  ASCVac-1, a Multi-Peptide Chimeric Vaccine, Protects Mice Against Ascaris suum Infection.

Authors:  Ana Clara Gazzinelli-Guimarães; Denise Silva Nogueira; Chiara Cássia Oliveira Amorim; Fabrício Marcus Silva Oliveira; Anderson Coqueiro-Dos-Santos; Samuel Alexandre Pimenta Carvalho; Lucas Kraemer; Fernando Sérgio Barbosa; Vanessa Gomes Fraga; Flaviane Vieira Santos; Joseane Camilla de Castro; Remo Castro Russo; Milena Apetito Akamatsu; Paulo Lee Ho; Maria Elena Bottazzi; Peter J Hotez; Bin Zhan; Daniella Castanheira Bartholomeu; Lilian Lacerda Bueno; Ricardo Toshio Fujiwara
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

8.  Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study.

Authors:  Fatemeh Ghafouri; Reza Ahangari Cohan; Hilda Samimi; Ali Hosseini Rad S M; Mahmood Naderi; Farshid Noorbakhsh; Vahid Haghpanah
Journal:  JMIR Bioinform Biotech       Date:  2022-07-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.